One third of R&D expenses were spent into clinical studies in pharma industry

Pharmaceutical companies reportedly are spending 30% of their R&D expenses into the clinical study field.

Moreover, they are also spending 13% into developing biologics which have recently brought various achievements.

The Korea Health Industry Development Institute analyzed how much 577 drug manufacturers spend money into R&D in 2016, and the analysis result showed they spend total KRW 1.839...